The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

President-elect Donald J. Trump has announced his selection of Robert F. Kennedy Jr as his chosen nominee for secretary of ...

Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Health care apps like MyChart, mySugr, GoodRx, and Smoke Free can enhance patient care through accessibility, convenience, ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...

Young adults with type 2 diabetes and lower incomes face significantly higher mortality risks, highlighting socioeconomic ...

The data come from a systematic review of over 90 studies between 1952 through 2022, which found that both prevalence and ...

Investigators were seeking a greater understanding of risk factors for hidradenitis suppurativa, a chronic inflammatory skin ...

The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...

JAK inhibitors like baricitinib, ritlecitinib, and brepocitinib show promise in treating alopecia areata, with baricitinib ...